Charmacy Pharmaceutical Co., Ltd.
HKEX:2289.HK
9.3 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2,347.185 | 2,134.559 | 2,269.074 | 2,288.2 | 1,887.079 | 1,800.604 | 1,993.014 | 2,130.951 | 1,860.759 | 1,784.695 | 1,708.088 | 1,913.258 | 2,021.988 | 2,191.894 | 1,903.942 | 1,891.832 | 1,777.949 | 1,761.736 | 1,635.397 | 1,564.533 | 1,449.526 | 753.515 |
Cost of Revenue
| 2,182.22 | 1,984.89 | 2,130.361 | 2,141.117 | 1,765.553 | 1,698.397 | 1,861.104 | 2,012.867 | 1,741.441 | 1,698.114 | 1,574.021 | 1,824.965 | 1,875.159 | 2,109.214 | 1,779.202 | 1,811.584 | 1,678.351 | 1,680.647 | 1,551.784 | 1,499.497 | 1,378.121 | 719.405 |
Gross Profit
| 164.965 | 149.669 | 138.713 | 147.083 | 121.527 | 102.207 | 131.91 | 118.085 | 119.318 | 86.581 | 134.067 | 88.293 | 146.829 | 82.68 | 124.739 | 80.249 | 99.598 | 81.089 | 83.613 | 65.036 | 71.405 | 34.11 |
Gross Profit Ratio
| 0.07 | 0.07 | 0.061 | 0.064 | 0.064 | 0.057 | 0.066 | 0.055 | 0.064 | 0.049 | 0.078 | 0.046 | 0.073 | 0.038 | 0.066 | 0.042 | 0.056 | 0.046 | 0.051 | 0.042 | 0.049 | 0.045 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 23.271 | 28.643 | 18.89 | 31.423 | 18.313 | 29.447 | 18.955 | 29.238 | 16.462 | 24.03 | 22.474 | 28.332 | 25.827 | 26.005 | 23.498 | 17.094 | 21.661 | 17.706 | 22.674 | 21.556 | 15.606 | 9.291 |
Selling & Marketing Expenses
| 62.94 | 59.465 | 63.002 | 58.934 | 53.897 | 51.13 | 52.318 | 45.28 | 40.695 | 41.285 | 36.115 | 37.8 | 36.183 | 35.858 | 32.22 | 29.643 | 22.135 | 21.792 | 18.504 | 20.098 | 15.659 | 8.939 |
SG&A
| 87.08 | 88.459 | 82.345 | 92.56 | 72.489 | 80.038 | 71.521 | 82.779 | 60.264 | 70.148 | 58.002 | 67.294 | 62.892 | 64.883 | 54.674 | 48.851 | 43.796 | 39.498 | 41.178 | 41.654 | 31.265 | 18.23 |
Other Expenses
| 38.544 | 28.999 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.216 | -0.128 | -0.128 |
Operating Expenses
| 125.624 | 117.457 | 89.14 | 35.31 | 80.774 | 84.884 | 78.533 | 90.219 | 64.724 | 74.683 | 64.12 | 74.948 | 68.604 | 67.873 | 57.681 | 46.649 | 43.588 | 65.318 | 38.36 | 41.718 | 30.689 | 18.102 |
Operating Income
| 39.341 | 32.212 | 51.76 | 48.997 | 44.49 | 18.126 | 56.297 | 31.936 | 56.14 | 13.289 | 71.909 | 18.024 | 81.057 | 15.684 | 68.034 | 30.022 | 53.437 | 41.591 | 42.435 | 23.382 | 40.14 | 17.192 |
Operating Income Ratio
| 0.017 | 0.015 | 0.023 | 0.021 | 0.024 | 0.01 | 0.028 | 0.015 | 0.03 | 0.007 | 0.042 | 0.009 | 0.04 | 0.007 | 0.036 | 0.016 | 0.03 | 0.024 | 0.026 | 0.015 | 0.028 | 0.023 |
Total Other Income Expenses Net
| -0.413 | 0.05 | -16.602 | 0.185 | -18.642 | -19.676 | -21.767 | -18.939 | -14.395 | -15.862 | -14.29 | -18.683 | -16.742 | -13.734 | -10.126 | 2.084 | 0.833 | -33.731 | -8.72 | -10 | -7.587 | -5.708 |
Income Before Tax
| 38.928 | 32.262 | 35.157 | 96.206 | 25.848 | -1.55 | 34.53 | 12.997 | 41.746 | -2.574 | 57.618 | -0.659 | 64.315 | 1.95 | 57.908 | 26.852 | 49.229 | 7.86 | 33.715 | 13.382 | 32.553 | 11.484 |
Income Before Tax Ratio
| 0.017 | 0.015 | 0.015 | 0.042 | 0.014 | -0.001 | 0.017 | 0.006 | 0.022 | -0.001 | 0.034 | -0 | 0.032 | 0.001 | 0.03 | 0.014 | 0.028 | 0.004 | 0.021 | 0.009 | 0.022 | 0.015 |
Income Tax Expense
| 12.181 | 7.27 | 8.805 | 26.373 | 5.209 | 1.258 | 8.569 | 3.314 | 10.872 | 0.422 | 15.314 | 0.098 | 18.992 | 0.616 | 14.946 | 7.157 | 12.467 | 6.735 | 8.481 | 3.386 | 6.104 | 2.373 |
Net Income
| 26.747 | 24.992 | 26.353 | 69.833 | 20.639 | -2.808 | 25.961 | 9.683 | 30.873 | -2.151 | 42.305 | -0.207 | 45.64 | 1.841 | 42.919 | 19.696 | 36.763 | 1.125 | 25.234 | 9.996 | 26.449 | 9.111 |
Net Income Ratio
| 0.011 | 0.012 | 0.012 | 0.031 | 0.011 | -0.002 | 0.013 | 0.005 | 0.017 | -0.001 | 0.025 | -0 | 0.023 | 0.001 | 0.023 | 0.01 | 0.021 | 0.001 | 0.015 | 0.006 | 0.018 | 0.012 |
EPS
| 0.25 | 0.23 | 0.24 | 0.65 | 0.19 | -0.026 | 0.24 | 0.09 | 0.29 | -0.02 | 0.39 | -0.002 | 0.42 | 0.017 | 0.4 | 0.18 | 0.34 | 0.014 | 0.32 | 0.12 | 0.33 | 0.11 |
EPS Diluted
| 0.25 | 0.23 | 0.24 | 0.65 | 0.19 | -0.026 | 0.24 | 0.09 | 0.29 | -0.02 | 0.39 | -0.002 | 0.42 | 0.017 | 0.4 | 0.18 | 0.34 | 0.014 | 0.32 | 0.12 | 0.33 | 0.11 |
EBITDA
| 83.435 | 66.39 | 61.702 | 61.177 | 59.853 | 33.529 | 69.989 | 43.827 | 66.043 | 23.282 | 83.02 | 27.978 | 89.544 | 23.034 | 74.805 | 35.986 | 58.951 | 46.162 | 46.846 | 28.117 | 45.13 | 20.177 |
EBITDA Ratio
| 0.036 | 0.031 | 0.027 | 0.027 | 0.032 | 0.019 | 0.035 | 0.021 | 0.035 | 0.013 | 0.049 | 0.015 | 0.044 | 0.011 | 0.039 | 0.019 | 0.033 | 0.026 | 0.029 | 0.018 | 0.031 | 0.027 |